198 related articles for article (PubMed ID: 12784658)
1. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
2. [Splenic lymphoma with circulating villous lymphocytes. Study of 6 patients].
Batlle M; Ribera JM; Feliu E; Millá F; Sans-Sabrafén J; Villamor N; Marill N; Woessner S
Sangre (Barc); 1993 Aug; 38(4):267-71. PubMed ID: 8235939
[TBL] [Abstract][Full Text] [Related]
3. Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature.
Labouyrie E; Marit G; Vial JP; Lacombe F; Fialon P; Bernard P; de Mascarel A; Merlio JP
Mod Pathol; 1997 Oct; 10(10):1015-20. PubMed ID: 9346181
[TBL] [Abstract][Full Text] [Related]
4. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M; Schechter GP
Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
[TBL] [Abstract][Full Text] [Related]
5. [Splenic lymphoma with circulating villous lymphocytes].
Colović M; Janković G; Colović R; Mijović A; Antunović P
Srp Arh Celok Lek; 1994; 122(3-4):103-4. PubMed ID: 17972822
[TBL] [Abstract][Full Text] [Related]
6. Splenic B-cell lymphoma with villous lymphocytes (SLVL). A lymphocytic lymphoma simulating hairy cell leukemia. A study of 8 cases.
Valensi F; Durand V; Bastenaire B; Flandrin G
Nouv Rev Fr Hematol (1978); 1990; 32(6):409-14. PubMed ID: 2101874
[TBL] [Abstract][Full Text] [Related]
7. [Splenic marginal zone lymphoma associated with antiphospholipid antibodies].
Yokoi T; Mori S; Sugimoto H; Komiyama Y; Uemura Y; Tanijiri R; Nakai K; Matsumoto N; Zen K; Amakawa R; Kishimoto Y; Ieko M; Takahashi H; Fukuhara S
Rinsho Ketsueki; 2004 Oct; 45(10):1095-9. PubMed ID: 15553043
[TBL] [Abstract][Full Text] [Related]
8. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
[TBL] [Abstract][Full Text] [Related]
9. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Troussard X; Cornet E
Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839
[TBL] [Abstract][Full Text] [Related]
10. [Splenic lymphoma with villous lymphocytes. A clinical case].
Brambilla Pisoni G; Montalbetti L; Paparella P; Neri G
Minerva Med; 1997; 88(7-8):311-6. PubMed ID: 9304075
[TBL] [Abstract][Full Text] [Related]
11. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
12. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL.
Yamazaki K; Shimizu S; Negami T; Sawada K; Nanasawa H; Ohta M; Konda S; Okuda K
Cancer; 1994 Jul; 74(1):61-5. PubMed ID: 8004584
[TBL] [Abstract][Full Text] [Related]
13. Splenic marginal zone lymphoma with and without villous lymphocytes.
Matutes E
Curr Treat Options Oncol; 2007 Apr; 8(2):109-16. PubMed ID: 17680218
[TBL] [Abstract][Full Text] [Related]
14. [Splenic lymphoma with villous lymphocytes and complex chromosomal abnormality].
Hamamoto K; Ohno T; Ogawa H; Date M; Kimura T; Fukuhara S
Rinsho Ketsueki; 1997 Jun; 38(6):544-9. PubMed ID: 9248332
[TBL] [Abstract][Full Text] [Related]
15. Splenic lymphocytes with circulating villous lymphocytes--a case report.
Gupta D; Rani S; Singh T; Madan S
Indian J Cancer; 1996 Dec; 33(4):183-6. PubMed ID: 9254997
[TBL] [Abstract][Full Text] [Related]
16. Multiple M components in two patients with splenic lymphoma with villous lymphocytes.
Colović N; Miljić P; Colović M; Milosević-Jovcić N
Ann Hematol; 2006 Jan; 85(1):51-4. PubMed ID: 16007426
[TBL] [Abstract][Full Text] [Related]
17. [Primary diffuse large B-cell lymphosarcoma of the spleen].
Magomedova AU; Kravchenko SK; Kremenetskaia AM; Kaplanskaia IB; Zybunova EE; Samoĭlova RS; Vorob'ev IA; Obukhova TN; Ryzhko VV; Zvonkov EE; Vorob'ev AI
Ter Arkh; 2007; 79(7):62-6. PubMed ID: 17802793
[TBL] [Abstract][Full Text] [Related]
18. Blastic transformation of splenic lymphoma with villous lymphocytes after a well-controlled chronic phase of more than 10 years.
Kuwayama M; Machii T; Yamaguchi M; Yamaguti K; Kitani T; Kanakura Y
Int J Hematol; 2000 Feb; 71(2):167-71. PubMed ID: 10745627
[TBL] [Abstract][Full Text] [Related]
19. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996
[TBL] [Abstract][Full Text] [Related]
20. [Splenic marginal zone B-cell lymphoma with bilateral renal invasion after splenectomy].
Hoshino T; Iriuchijima H; Ogawa Y; Irisawa H; Jinbo T
Rinsho Ketsueki; 2008 Jan; 49(1):35-9. PubMed ID: 18277594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
